Oncology & Cancer

'Embattled' breast cancer drugs could be revived by new discovery

More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells—known as the PI3 kinase (PI3K) pathway—but efforts to develop therapies targeting this pathway have ...

page 2 from 22